Daniel Jones Selected Research

Vascular Diseases (Vascular Disease)

5/2006	AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
5/2006	AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Jones Research Topics

Disease

12	Neoplasms (Cancer) 02/2022 - 08/2007
3	Cardiomyopathies (Cardiomyopathy) 01/2021 - 11/2015
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 05/2017
3	Diarrhea 01/2021 - 01/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2010
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2009 - 09/2006
3	Hypertension (High Blood Pressure) 06/2008 - 04/2004
2	Thrombosis (Thrombus) 01/2021 - 02/2014
2	Headache (Headaches) 01/2021 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2007
2	Dizziness (Lightheadedness) 01/2021 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2018
2	Necrosis 01/2018 - 08/2015
2	Inflammation (Inflammations) 02/2017 - 05/2016
2	Atherosclerosis 02/2017 - 04/2004
2	Nausea 01/2017 - 02/2005
2	Pain (Aches) 01/2017 - 01/2013
2	Vomiting 01/2017 - 02/2005
2	Philadelphia Chromosome 08/2009 - 09/2006
2	Chronic Renal Insufficiency 06/2008 - 06/2008
2	Sleep Apnea Syndromes (Sleep Apnea) 06/2008 - 06/2008
2	Vascular Diseases (Vascular Disease) 05/2006 - 05/2006
2	Gallstones (Gallstone) 02/2004 - 01/2004
2	Morbid Obesity 02/2004 - 01/2004
2	Renal Artery Obstruction (Renal Artery Stenosis) 09/2003 - 10/2002
1	Breast Neoplasms (Breast Cancer) 02/2022
1	Carcinoma (Carcinomatosis) 02/2022
1	Littoral cell angioma of the spleen 02/2022
1	Ventricular Tachycardia 01/2022
1	Out-of-Hospital Cardiac Arrest 01/2022
1	Infections 01/2022
1	Frailty 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Cough 01/2021
1	Contusions 01/2021
1	Hairy Cell Leukemia 01/2021
1	Pheochromocytoma 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Disease Progression 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2020
1	Leukemia 10/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020
1	Neointima 12/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2019
1	Abscess 04/2019
1	Lung Neoplasms (Lung Cancer) 03/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Heart Failure 01/2019
1	Hypoxia (Hypoxemia) 12/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Arteritis 02/2017

Drug/Important Bio-Agent (IBA)

4	ibrutinibIBA 01/2021 - 05/2017
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 05/2017
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2012
3	Tyrosine Kinase InhibitorsIBA 10/2020 - 08/2009
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2018
2	reveromycin AIBA 01/2018 - 08/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 04/2010
2	Biological ProductsIBA 02/2017 - 08/2015
2	Imatinib Mesylate (Gleevec)FDA Link 09/2009 - 09/2006
2	Drug CombinationsIBA 06/2008 - 06/2008
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2004 - 01/2004
1	Anastrozole (Arimidex)FDA LinkGeneric 02/2022
1	acalabrutinibIBA 01/2021
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021
1	CatecholsIBA 01/2021
1	GalliumIBA 01/2021
1	Loperamide (Imodium)FDA LinkGeneric 01/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2021
1	purineIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 10/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 10/2020
1	Genetic Markers (Genetic Marker)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	LipidsIBA 12/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Oxygen (Dioxygen)IBA 12/2018
1	Decitabine FDA Link 01/2018
1	Vorinostat FDA Link 01/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2018
1	Green Fluorescent ProteinsIBA 02/2017

Therapy/Procedure

14	Therapeutics 01/2021 - 09/2006
3	Radiotherapy 02/2022 - 01/2019
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2005 - 01/2004
2	Laparotomy 04/2019 - 08/2007
2	Secondary Prevention 05/2006 - 05/2006
2	Cholecystectomy 02/2004 - 01/2004
2	Stents 09/2003 - 10/2002
1	Splenectomy 02/2022
1	Segmental Mastectomy (Lumpectomy) 02/2022
1	Catheter Ablation 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Cell Transplantation 01/2021
1	Behavior Control 10/2020
1	Liver Transplantation 06/2019
1	Radiofrequency Ablation 03/2019
1	Heart-Assist Devices 01/2019
1	Self-Testing 01/2018